IL41825A - Pyridine derivatives their preparation and pharmaceutical compositions containing them - Google Patents

Pyridine derivatives their preparation and pharmaceutical compositions containing them

Info

Publication number
IL41825A
IL41825A IL41825A IL4182573A IL41825A IL 41825 A IL41825 A IL 41825A IL 41825 A IL41825 A IL 41825A IL 4182573 A IL4182573 A IL 4182573A IL 41825 A IL41825 A IL 41825A
Authority
IL
Israel
Prior art keywords
group
alk
formula
compound
salt
Prior art date
Application number
IL41825A
Other languages
English (en)
Other versions
IL41825A0 (en
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of IL41825A0 publication Critical patent/IL41825A0/xx
Publication of IL41825A publication Critical patent/IL41825A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL41825A 1972-04-04 1973-03-19 Pyridine derivatives their preparation and pharmaceutical compositions containing them IL41825A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1528072A GB1437781A (en) 1972-04-04 1972-04-04 Pyridine derivatives having hypoglycaemic activity

Publications (2)

Publication Number Publication Date
IL41825A0 IL41825A0 (en) 1973-05-31
IL41825A true IL41825A (en) 1977-03-31

Family

ID=10056262

Family Applications (1)

Application Number Title Priority Date Filing Date
IL41825A IL41825A (en) 1972-04-04 1973-03-19 Pyridine derivatives their preparation and pharmaceutical compositions containing them

Country Status (20)

Country Link
JP (1) JPS49100091A (ja)
AR (1) AR208269A1 (ja)
AT (1) AT339301B (ja)
BE (1) BE797715A (ja)
BG (1) BG20352A3 (ja)
CA (1) CA999868A (ja)
CH (1) CH576961A5 (ja)
CS (1) CS183689B2 (ja)
DD (1) DD106834A5 (ja)
DE (1) DE2316881A1 (ja)
ES (1) ES413279A1 (ja)
FR (1) FR2182933B1 (ja)
GB (1) GB1437781A (ja)
HU (1) HU165731B (ja)
IE (1) IE37412B1 (ja)
IL (1) IL41825A (ja)
NL (1) NL7304610A (ja)
PL (1) PL96043B1 (ja)
RO (2) RO62274A (ja)
ZA (1) ZA731853B (ja)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409227A (en) 1979-08-09 1983-10-11 The Dow Chemical Co. 4-(((Heterocyclo)thio)methyl)benzoic acids, esters and amides and their pharmaceutical use
DK0521549T3 (da) * 1991-07-03 1995-12-27 Unilever Plc Chokoladefyldninger indeholdende et additiv mod dannelse af gråt overtræk
ES2072085T3 (es) * 1991-07-03 1995-07-01 Unilever Nv Composiciones de chocolate mejoradas.
US5453433A (en) * 1994-05-13 1995-09-26 Sterling Winthrop Inc. Thiadiazoles and antipicornaviral compositions
US6043247A (en) * 1996-04-19 2000-03-28 Novo Nordisk A/S Modulators of molecules with phosphotyrosine recognition units
JP2000509373A (ja) * 1996-04-19 2000-07-25 ノボ ノルディスク アクティーゼルスカブ ホスホチロシン認識ユニットを有する分子のモジュレーター
US6329372B1 (en) 1998-01-27 2001-12-11 Celltech Therapeutics Limited Phenylalanine derivatives
ES2226413T3 (es) 1998-02-26 2005-03-16 Celltech Therapeutics Limited Derivados de fenilalanina como inhibidores de alfa-4 integrinas.
GB9805655D0 (en) 1998-03-16 1998-05-13 Celltech Therapeutics Ltd Chemical compounds
US6521626B1 (en) 1998-03-24 2003-02-18 Celltech R&D Limited Thiocarboxamide derivatives
GB9811159D0 (en) 1998-05-22 1998-07-22 Celltech Therapeutics Ltd Chemical compounds
GB9811969D0 (en) * 1998-06-03 1998-07-29 Celltech Therapeutics Ltd Chemical compounds
GB9812088D0 (en) 1998-06-05 1998-08-05 Celltech Therapeutics Ltd Chemical compounds
GB9814414D0 (en) * 1998-07-03 1998-09-02 Celltech Therapeutics Ltd Chemical compounds
GB9821061D0 (en) 1998-09-28 1998-11-18 Celltech Therapeutics Ltd Chemical compounds
GB9821222D0 (en) 1998-09-30 1998-11-25 Celltech Therapeutics Ltd Chemical compounds
GB9825652D0 (en) 1998-11-23 1999-01-13 Celltech Therapeutics Ltd Chemical compounds
GB9826174D0 (en) 1998-11-30 1999-01-20 Celltech Therapeutics Ltd Chemical compounds
US6518283B1 (en) 1999-05-28 2003-02-11 Celltech R&D Limited Squaric acid derivatives
US6534513B1 (en) 1999-09-29 2003-03-18 Celltech R&D Limited Phenylalkanoic acid derivatives
US6455539B2 (en) 1999-12-23 2002-09-24 Celltech R&D Limited Squaric acid derivates
ATE375330T1 (de) 2000-04-17 2007-10-15 Ucb Pharma Sa Enamin-derivate als zell-adhäsionsmoleküle
US6545013B2 (en) 2000-05-30 2003-04-08 Celltech R&D Limited 2,7-naphthyridine derivatives
US6403608B1 (en) 2000-05-30 2002-06-11 Celltech R&D, Ltd. 3-Substituted isoquinolin-1-yl derivatives
EP1301488A1 (en) 2000-07-07 2003-04-16 Celltech R&D Limited Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists
WO2002010136A1 (en) 2000-08-02 2002-02-07 Celltech R & D Limited 3-substituted isoquinolin-1-yl derivatives
KR100965201B1 (ko) * 2001-06-12 2010-06-24 웰스테트 테라퓨틱스 코포레이션 대사 질환의 치료용 화합물
GB0405033D0 (en) * 2004-03-05 2004-04-07 Karobio Ab Novel pharmaceutical compositions
TWI490214B (zh) 2008-05-30 2015-07-01 艾德克 上野股份有限公司 苯或噻吩衍生物及該等作為vap-1抑制劑之用途
WO2015000900A2 (en) * 2013-07-01 2015-01-08 Givaudan Sa Organic compounds
WO2016167153A1 (ja) * 2015-04-15 2016-10-20 長谷川香料株式会社 ピリジン誘導体またはその塩を有効成分とする香味変調剤
US11096909B2 (en) 2016-04-06 2021-08-24 University Of Oulu Compounds for use in the treatment of cancer

Also Published As

Publication number Publication date
JPS49100091A (ja) 1974-09-20
GB1437781A (en) 1976-06-03
FR2182933A1 (ja) 1973-12-14
IL41825A0 (en) 1973-05-31
FR2182933B1 (ja) 1976-05-14
ATA286773A (de) 1977-02-15
RO62274A (fr) 1977-12-15
CS183689B2 (en) 1978-07-31
RO63069A (fr) 1978-08-15
NL7304610A (ja) 1973-10-08
HU165731B (ja) 1974-10-28
IE37412B1 (en) 1977-07-20
DD106834A5 (ja) 1974-07-05
CH576961A5 (ja) 1976-06-30
AT339301B (de) 1977-10-10
BG20352A3 (bg) 1975-11-05
IE37412L (en) 1973-10-04
ES413279A1 (es) 1976-01-01
AR208269A1 (es) 1976-12-20
PL96043B1 (pl) 1977-11-30
CA999868A (en) 1976-11-16
BE797715A (fr) 1973-10-03
DE2316881A1 (de) 1973-10-11
ZA731853B (en) 1974-01-30

Similar Documents

Publication Publication Date Title
IL41825A (en) Pyridine derivatives their preparation and pharmaceutical compositions containing them
US4036844A (en) Aryloxypyridines
US4053607A (en) Aryloxypyridine for treating hyperglycaemia
JP6033835B2 (ja) カルシウム感知受容体モジュレーターとしてのベンゾ[b][1,4]オキサジン誘導体
JPS6089474A (ja) モルフイナン誘導体,その製造方法,及び該化合物を含有する抗腫瘍剤
CA1288102C (en) Pyridine derivatives, their preparation and their use
JP2020520949A (ja) 組成物、並びにミトコンドリア脱共役剤を調製及び使用する方法
KR850000216B1 (ko) 피페라진 유도체의 제조방법
PL95166B1 (ja)
IE912492A1 (en) 1,4-disubstituted piperazines
JPH0717589B2 (ja) 新規1,3―ジカルボニル化合物およびその組成物
US4727072A (en) 3-alkoxy-2-aminopropylamines compositions and use as cardiovascular agents
DK168010B1 (da) Tetrahydroisoquinolinforbindelser og farmaceutisk middel indeholdende en saadan forbindelse
CS204008B2 (en) Process for preparing new derivatives of 0-/3-amino-2-hydroxypropyl/-amidoxime
SU1001856A3 (ru) Способ получени фенилпиперазинпроизводных 1,3,4-оксадиазолилфенола или их кислотно-аддитивных солей
KR100372312B1 (ko) 신규의히드록시믹산유도체,그를포함한약제학적조성물및그의제조방법
JPS62252780A (ja) 新規なインデノチアゾ−ル誘導体及びその製造法
IE55377B1 (en) 1,5-diphenylpyrazolin-3-one compounds,method for preparing them,and pharmaceutical compositions containing these compounds
US5834491A (en) Bis(2-aminopyridine)s, preparation method therefor and use thereof for controlling parasitic infections
CA2077122A1 (en) Thiourea derivatives and antimicrobial agent and antiulcer agent containing the same
TW406074B (en) Heterocyclyloxybenzoylguanidines
JPH02115166A (ja) ピリジルケトオキシムエーテル誘導体
US4758563A (en) 3-alkoxy-2-aminopropyamines, cardiovascular compositions and use
JPS61212562A (ja) 新規ピリジンメタノール誘導体及びそれを含有する医薬組成物
JPS62212386A (ja) 2−ピリジルメチルベンズイミダゾ−ル誘導体